Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
Clinical trial NCT04724369 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04724369
- Sponsor
- Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2026-07-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.